Biosimilar medicines are available in therapy areas which represent 65% of the biologics market by value

Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
Biosimilars Market Review 2023 18 September 2023 The purpose of this Market Review is to provide a…
Across Europe - on average - 26% of all generic medicines… 4 May 2023 Affordable generic medicines available on the market just 10 years…
From disruption to care for cancer patients 5 September 2022 Biosimilar medicines are biologic medicines that can be used safely…